PDS Biotechnology Corporation (PDSB)

NASDAQ: PDSB · IEX Real-Time Price · USD

2.950

-0.080 (-2.64%)

At close: Jul 2, 2024, 4:00 PM

3.000

+0.050 (1.69%)

After-hours: Jul 2, 2024, 6:21 PM EDT

PDS Biotechnology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2013
Net Income	-42.94	-40.85	-16.92	-14.85	-7	Upgrade
Depreciation & Amortization	0.18	0.24	0.25	0.18	0.1	Upgrade
Share-Based Compensation	7.61	5.2	4.07	0.43	3.74	Upgrade
Other Operating Activities	1.51	9.71	0.11	1.09	-14.92	Upgrade
Operating Cash Flow	-33.64	-25.71	-12.49	-13.15	-18.07	Upgrade
Capital Expenditures	0	0	0	0	0.28	Upgrade
Acquisitions	0	0	0	0	29.11	Upgrade
Investing Cash Flow	0	0	0	0	29.38	Upgrade
Share Issuance / Repurchase	16.44	10.01	48.89	29.83	0.75	Upgrade
Debt Issued / Paid	-0.06	24.55	0	0	0	Upgrade
Other Financing Activities	-	-0.27	-	-	-	Upgrade
Financing Cash Flow	16.38	34.29	48.89	29.83	0.75	Upgrade
Net Cash Flow	-17.26	8.58	36.4	16.68	12.06	Upgrade
Free Cash Flow	-33.64	-25.71	-12.49	-13.15	-17.8	Upgrade
Free Cash Flow Per Share	-1.09	-0.90	-0.49	-0.79	-3.66	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).